Cerus Corporation (CERS) vs 908 Devices Inc. (MASS)

Cerus Corporation and 908 Devices Inc. are both Medical Devices companies. Cerus Corporation and 908 Devices Inc. are of similar size ($524.0M and $492.7M). Cerus Corporation grew revenue faster over the last twelve months: 14.6% against 13.4%. Cerus Corporation has the higher net margin (−2.73% vs −57.0%) and the higher return on invested capital (−1.27% vs −96.4%). Across the 18 metrics below, Cerus Corporation leads on 11 and 908 Devices Inc. on 7.

Valuation

Metric CERS MASS Medical Devices median
P/E n/m n/m 22.18
P/S 2.12 7.09 2.70
P/B 7.43 3.40 2.46
Price to free cash flow n/m 701.80 22.53
EV/EBITDA 8,092.91 n/m 11.78
EV/Sales 2.15 5.53 2.38
Earnings yield (1.34%) (8.22%) (8.22%)
Free cash flow yield (0.35%) 0.14% (7.80%)

Profitability

Metric CERS MASS Medical Devices median
Gross margin 57.16% 52.16% 56.01%
Operating margin (0.65%) (63.98%) (15.03%)
Net margin (2.73%) (56.96%) (20.40%)
Free cash flow margin (0.74%) 1.01% (7.24%)
Return on equity (10.69%) (25.15%) (15.32%)
Return on assets (3.24%) (17.81%) (19.72%)
Return on invested capital (1.27%) (96.41%) (10.33%)

Growth

Metric CERS MASS Medical Devices median
Revenue growth (TTM) 14.61% 13.35% 8.80%
EPS growth (last fiscal year) 27.27% 125.47% —
Revenue growth, 5-year CAGR 15.40% 15.88% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CERS MASS Medical Devices median
Debt to equity 0.92 0.00 0.07
Current ratio 1.83 2.67 2.50
Net debt to EBITDA (0.14) 3.17 0.49

Dividend

Metric CERS MASS Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric CERS MASS Medical Devices median
Market cap 523.96m 492.69m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack